RANI Earnings Rani Therapeutics Holdings, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–19 of 19
| Q1 2026 | 2026-03-31 | -0.04 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -0.45 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.50 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.40 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.22 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -1.05 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.78 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.55 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.29 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -1.33 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -1.06 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.70 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.33 | 2024-05-06 | 10-Q |
| FY 2023 | 2022-12-31 | -1.28 | 2024-03-20 | 10-K |
| Q3 2023 | 2022-09-30 | 0.93 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.60 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.29 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -0.43 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -0.16 | 2022-11-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.